Previous studies showed that knockout of osteopontin protected mice on a high-fat diet from obesity-induced hepatic steatosis (44), while anti-osteopontin antibodies attenuated NASH and hepatic fibrosis in NASH mouse models (45). This evidence concerns the gene SPP1 and metabolic dysfunction-associated steatohepatitis.